Evaluation of Thiol Disulfide, Ischemia Modified Albumin, and Prolidase Parameters in Patients With Localized Scleroderma
Keywords:
Adult, child, epidemiology, localized scleroderma, morpheaAbstract
Introduction: Localized scleroderma is a rare inflammatory skin disease that causes sclerosis in the dermis and subcutaneous tissue. Oxidative stress may play a role in the etiology or be responsible for the chronicity or progression of the disease.
Objectives: We aimed to investigate the presence of oxidative stress in patients with localized scleroderma by examining thiol disulfide balance, ischemia-modified albumin (IMA), and prolidase parameters.
Methods: Twenty patients over the age of 18, who were diagnosed with localized scleroderma both clinically and histopathologically and 20 control subjects were included in the study. Age, gender, age of disease onset, duration of the disease, and presence of accompanying systemic diseases were questioned and recorded. Lesion type and modified Rodnan and Lossi scores were calculated through dermatological examination. CRP, sedimentation rate, total thiol, native thiol, and disulfide levels indicated by the Erel profile, IMA level, and prolidase levels were measured and compared in both the patient and control groups.
Results: Levels of native thiol (p=0.958), total thiol (p=0.979), disulfide (p=0.449), (disulfide/native thiol%) (p=0.368), (disulfide/total thiol%) (p=0.361), (native thiol/total thiol%) (p=0.368), and prolidase (p=0.121) were similar in both patient and control groups. Only IMA was significantly different. No significant relationship was found between the levels of native thiol, total thiol, disulfide, (disulfide/native thiol), (disulfide/total thiol), IMA, prolidase, and Rodnan and Lossi scores.
Conclusion: According to the data obtained from this study, we can say that the thiol-disulfide balance is not disrupted and prolidase levels are not affected in localized scleroderma; however, IMA is negatively affected.
References
Papara C, De Luca DA, Bieber K, Vorobyev A, Ludwig RJ. Morphea: The 2023 update. Front Med (Lausanne). 2023; 13;10:1108623. DOI: 10.3389/fmed.2023.1108623. PMID: 36860340; PMCID: PMC9969991.
Florez-Pollack S, Kunzler E, Jacobe HT. Morphea: Current concepts. Clin Dermatol. 2018;36(4):475-486. DOI: 10.1016/j.clindermatol.2018.04.005. Epub 2018 Apr 10. PMID: 30047431.
Torok KS, Li SC, Jacobe HM, et al. Immunopathogenesis of Pediatric Localized Scleroderma. Front Immunol. 2019;10:908. Published 2019 Apr 30. doi:10.3389/fimmu.2019.00908.
Abbas L, Joseph A, Kunzler E, et al. Morphea: progress to date and the road ahead. Ann Transl Med.2021;9(5):437. DOI: 10.21037/atm-20-6222. PMID: 33842658; PMCID: PMC8033330.
Baba SP, BhatnAGAr A. Role of tiyols ın oxidative stres. Curr Opin Toxicol.2018 ;7:133-139. DOI: 10.1016/j.cotox.2018.03.005. PMID: 30338308.
Erel Ö, Erdoğan S Thiol-disulfide homeostasis: an integrated approach with biochemical and clinical aspects. Turk J Med Sci .2020; 50: 1728-1738 © Tübitak DOI:10.3906/sag-2003-64.
Nakai, K. Tsuruta, D. What Are Reactive Oxygen Species, Free Radicals, and Oxidative Stress in Skin Diseases? Int. J. Mol. Sci. 2021 ;22: 10799. DOI: 10.3390/ijms221910799. PMID: 34639139; PMCID: PMC8509443.
Georgescu SR, Mitran CI, Mitran MI, Matei C, Popa GL, Erel O, Tampa M. Thiol-Disulfide Homeostasis in Skin Diseases. J Clin Med. 2022 9;11(6):1507. DOI: 10.3390/jcm11061507. PMID: 35329832; PMCID: PMC8954849
Tampa M, Mitran CI, Mitran MI, Amuzescu A, Matei C, Georgescu SR. Ischemia-Modified Albumin-A Potential New Marker of Oxidative Stress in Dermatological Diseases. Medicina (Kaunas). 2022 May 17;58(5):669. DOI: 10.3390/medicina58050669. PMID: 35630086; PMCID: PMC9147831.
Eni-Aganga I, Lanaghan ZM, Balasubramaniam M, Dash C, Pandhare J. PROLIDASE: A Review from Discovery to its Role in Health and Disease. Front Mol Biosci. 2021;8:723003. Published 2021 Aug 31. DOI:10.3389/fmolb.2021.723003.
Radi R, Trujillo M. Special issue on "Free Radical and Redox Biochemistry of Thiols". Free Radic Res. 2016;50(2):123-125. DOI:10.3109/10715762.2015.1121254.
Chianeh YR, Prabhu K. Protein Tiyols as an indication of oxidative stres. Arch. Med. Res. 2014; 23(3): 443-56. DOI:10.17827/aktd.72428.
Erel O, Neselioglu S. A novel and automated assay for hiol-disulphide homeostasis. Clin Biochem. 2014;47(18):326-332. DOI: 10.1016/j.clinbiochem.2014.09.026 PMID: 25304913.
Sbarouni E, Georgiadou P, Voudris V. Ischemia modified albumin changes - review and clinical implications. Clin Chem Lab Med 2011;49:177-84. DOI: 10.1515/CCLM.2011.037. Epub 2010 Nov 18. PMID: 21083441.
Guntas G, Sahin A, Duran S, et al. Evaluation of ischemia-modified albumin in patients with inflammatory bowel disease. Clin Lab. 2017; 63(2):341-7. DOI: 10.7754/Clin.Lab.2016.160623. PMID: 28182340.
Aşkın L, Serçelik A, Tanrıverdi O, Süsenbük A, Türkmen S, Aktürk E. Kardiyovasküler İskemik Olayların Yeni Bir Sistemik Göstergesi: İskemi modifiye albumin levels. MN Kardiyoloji 2019;26(3):198-202.
Ozdemir M, Kiyici A, Balevi A. Assessment of ischaemia-modified albumin level in patients with psoriasis. Clin Exp Dermatol. 2012; 37:610–4. DOI: 10.1111/j.1365-2230.2012.04384.x. Epub 2012 May 21. PMID: 22607558.
Bozkurt M, Yüksel H, Em S, et al. Serum prolidase enzyme activity and oxidative status in patients with Behçet's disease. Redox Rep. 2014; 19(2):59-64. DOI: 10.1179/1351000213Y.0000000072. Epub 2013 Nov 12. PMID: 24225260; PMCID: PMC6837555.
Altindag O, Erel O, Aksoy N, Selek S, Celik H, Karaoglanoglu M. Increased oxidative stress and its relation with collagen metabolism in knee osteoarthritis. Rheumatol Int. 2007;27:339–44. DOI: 10.1007/s00296-006-0247-8. Epub 2006 Nov 10. PMID: 17096092.
Yildiz A, Demirbag R, Yilmaz R, et al. The association of serum prolidase activity with the presence and severity of coronary artery disease. Coron Artery Dis. 2008;19(5):319–25. DOI: 10.1097/MCA.0b013e32830042ba. PMID: 18607169.
Aciksari G, Demir B, Uygun T, et al. Serum prolidase activity in patients with cardiac syndrome X. North Clin Istanb 2020;7(5):471–477. DOI: 10.14744/nci.2020.09086. PMID: 33163883; PMCID: PMC7603856.
Luo JY, Liu X, Jiang M, Zhao HP, Zhao JJ. Oxidative stress markers in blood in system in blood in systemic sclerosis: a meta-analysis. Mod Rheumatol. 2017;27:306-314. DOI: 10.1080/14397595.2016.1206510. Epub 2016 Jul 18. PMID: 27425641.
Vona R, Giovannetti A, Gambardella L, Malorni W, Pietraforte D, Straface E. Oxidative stress in the pathogenesis of systemic scleroderma: an overview. J Cell Mol Med. 2018;22:3308-3314. DOI: 10.1111/jcmm.13630. Epub 2018 Apr 17. PMID: 29664231; PMCID: PMC6010858.
Piera-Velazquez S, Jimenez SA. Oxidative Stress Induced by Reactive Oxygen Species (ROS) and NADPH Oxidase 4 (NOX4) in the Pathogenesis of the Fibrotic Process in Systemic Sclerosis: A Promising Therapeutic Target. J Clin Med. 2021;10(20):4791. Published 2021 Oct 19. DOI:10.3390/jcm10204791
Gabrielli A, Svegliati S, Moroncini G, Amico D. New insights into the role of oxidative stress in scleroderma fibrosis. Open Rheumatol J. 2012;6:87-95. DOI: 10.2174/1874312901206010087. Epub 2012 Jun 15. PMID: 22802906; PMCID: PMC3395898.
Abdulle AE, van Roon AM, Smit AJ, et al. Rapid free thiol rebound is a physiological response following cold-induced vasoconstriction in healthy humans, primary Raynaud and systemic sclerosis. Physiol Rep. 2019 Mar;7(6):e14017. DOI: 10.14814/phy2.14017. PMID: 3091.
Kundu D, Abraham D, Black CM, Denton CP, Bruckdorfer KR. Reduced levels of S-nitrosothiols in plasma of patients with systemic sclerosis and Raynaud’s phenomenon. Vascul Pharmacol. 2014;63: 178-181. DOI: 10.1016/j.vph.2014.09.003. Epub 2014 Oct 15. PMID: 25446164; PMCID: PMC4265732.
Grygiel-Gorniak B, Puszczewicz M. Oxidative damage and antioxidative therapy in systemic sclerosis. Mediators Inflamm. 2014;2014:389582. DOI: 10.1155/2014/389582. Epub 2014 Sep 8. PMID: 25313270; PMCID: PMC4172878.
Svegliati S, Spadoni T, Moroncini G, Gabrielli A. NADPH oxidase, oxidative stress and fibrosis in systemic sclerosis. Free Radic Biol Med. 2018 Sep;125:90-97. DOI: 10.1016/j.freeradbiomed.2018.04.554. Epub 2018 Apr 22. PMID: 29694853.
Dziedzic R, Wójcik K, Olchawa M, et al. Increased oxidative stress response in circulating blood of systemic sclerosis patients - relation to disease characteristics and inflammatory blood biomarkers. Semin Arthritis Rheum. 2023 Oct;62:152228. DOI: 10.1016/j.semarthrit.2023.152228. Epub 2023 Jun 9. PMID: 37429138.
Ogawa F, Shimizu K, Muroi E, et al. Increasing levels of serum antioxidant status, total antioxidant power, in systemic sclerosis. Clin Rheumatol 30, 921–925 (2011). DOI 10.1007/s10067-011-1695-4.
Kilinc F, Sener S, Akbas A, et al. Oxidative stress parameters in localized scleroderma patients. Arch Dermatol Res. 2016;308:625-629. DOI: 10.1007/s00403-016-1682-3. Epub 2016 Sep 3. PMID: 27591994.
Uzuncakmak TK, Koska MC, Ozkanli S, et al. Comparison of the tissue expressions of glutathione S transferase isoenzymes among patients with morphea and healthy controls: A preliminary study. Dermatol Ther. 2020 Nov;33(6):e14363. DOI: 10.1111/dth.14363. Epub 2020 Oct 8. PMID: 33002252.
Khanna D, Furst DE, Clements PJ, et al. Standardization of the modified Rodnan skin score for use in clinical trials of systemic sclerosis. J Scleroderma Relat Disord. 2017. DOI:10.5301/jsrd.5000231
Arkachaisri T, Vilaiyuk S, Torok KS, Medsger TA Jr: Development and initial validation of the localized scleroderma skin damage index and physician global assessment of disease damage: A proof-of-concept study. Rheumatology (Oxford) 2010;49:373-81. DOI: 10.1093/rheumatology/kep361. Epub 2009 Dec 14. PMID: 20008472; PMCID: PMC3498950.
. Bar-Or D, Lau E, Winkler JV. A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia-a preliminary report. J Emerg Med. 2000; 19(4):311-5. DOI: 10.1016/s0736-4679(00)00255-9. PMID: 11074321.
Myara I, Myara I, Marcon P, Lemonnier A, Chateliér B, Mangeot M. Determination of prolinase activity in plasma. Application to liver disease and its relation with prolidase activity. Clin Biochem. 1985 Aug;18(4):220-3. DOI: 10.1016/s0009-9120(85)80043-6. PMID: 4042319.
Surazynski A, Surazynski A, Miltyk W, Prokop I, Palka J. Prolidase-dependent regulation of TGF β (corrected) and TGF β receptor expressions in human skin fibroblasts. Eur J Pharmacol. 2010 Dec 15;649(1-3):115-9. DOI: 10.1016/j.ejphar.2010.09.034. Epub 2010 Sep 21. PMID: 20868675.
Murrell DF. A radical proposal for the pathogenesis of scleroderma. J Am Acad Dermatol. 1993;28:78-85. DOI: 10.1016/0190-9622(93)70014-k. PMID: 8425975.
Celik A, Birer MN, Kilinc M. Serum prolidase activity in systemic sclerosis. Clin Rheumatol. 2017 Aug;36(8):1827-1832. DOI: 10.1007/s10067-017-3677-7. Epub 2017 May 22. PMID: 28534076.
Sambo P, Baroni SS, Luchetti M, et al. Oxidative stress in scleroderma: maintenance of scleroderma fibroblast phenotype by the constitutive up-regulation of reactive oxygen species generation through the NADPH oxidase complex pathway. Arthritis Rheum. 2001;44(11):2653–64. DOI: 10.1002/1529-0131(200111)44:11<2653::aid-art445>3.0.co;2-1. PMID: 11710721.
Devrim E, Erten S, Erguder IB, Namuslu M, Turgay M, Durak I. Malondialdehyde and nitric oxide levels in erythrocytes from patients with systemic sclerosis. Med Princ Pract. 2008;17(4):349-350. DOI:10.1159/000129620.
Riccieri V, Spadaro A, Fuksa L, Firuzi O, Saso L, Valesini G. Specific oxidative stress parameters differently correlate with nailfold capillaroscopy changes and organ involvement in systemic sclerosis. Clin Rheumatol. 2008;27:225-230. DOI: 10.1007/s10067-007-0769-9. Epub 2007 Oct 27. PMID: 17965907.
Rinnerthaler M, Bischof J, Streubel MK, Trost A, Richter K. Oxidative stresi in aging human skin. Biomolecules. 2015 Apr 21;5(2):545-89. DOI: 10.3390/biom5020545. PMID: 25906193; PMCID: PMC4496685.
Apple FS. Clinical and analytical review of ischemia-modified albumin measured by the albumin cobalt binding test. Adv Clin Chem. 2005;39:1-10. DOI: 10.1016/s0065-2423(04)39001-3. PMID: 16013666.
Kor A, Maraş Y, Atalar E, Fırat Oğuz E, Gök K, Erel Ö. Ischemia-modified albumin levels are elevated, and thiol/disulfite homeostasis is impaired in Behçet’s disease. Ulus Romatol Derg 2022;14(1):15-22.
Kirmit A, Kader S, Aksoy M, Bal C, Nural C, Aslan O. Trace Elements and Oxidative Stress Status in Patients with Psoriasis. Adv. Dermatol. Allergol. 2020, 37, 333–39. DOI: 10.5114/ada.2020.94265. Epub 2020 Apr 7. PMID: 32792872; PMCID: PMC7394161.
Savas E, Aksoy N, Pehlivan Y, et al. Evaluation of oxidant and antioxidant status and relation with prolidase in systemic sclerosis. Wien Klin Wochenschr. 2014 Jun;126(11-12):341-6. DOI: 10.1007/s00508-014-0534-4. Epub 2014 May 14. PMID: 24825595
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Ayşe Akbaş, Orhan Sen, Fadime Kılınç , Salim Neselioglu, Gülhan Aksoy Saraç, Akın Aktaş
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Dermatology Practical & Conceptual applies a Creative Commons Attribution License (CCAL) to all works we publish (http://creativecommons.org/licenses/by-nc/4.0/). Authors retain the copyright for their published work.
How to Cite
Share
